351 related articles for article (PubMed ID: 16458371)
1. Improved transfection and new selectable markers for the rodent malaria parasite Plasmodium yoelii.
Jongco AM; Ting LM; Thathy V; Mota MM; Kim K
Mol Biochem Parasitol; 2006 Apr; 146(2):242-50. PubMed ID: 16458371
[TBL] [Abstract][Full Text] [Related]
2. Gene targeting in the rodent malaria parasite Plasmodium yoelii.
Mota MM; Thathy V; Nussenzweig RS; Nussenzweig V
Mol Biochem Parasitol; 2001 Apr; 113(2):271-8. PubMed ID: 11295181
[TBL] [Abstract][Full Text] [Related]
3. High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei.
Janse CJ; Ramesar J; Waters AP
Nat Protoc; 2006; 1(1):346-56. PubMed ID: 17406255
[TBL] [Abstract][Full Text] [Related]
4. The selectable marker human dihydrofolate reductase enables sequential genetic manipulation of the Plasmodium berghei genome.
de Koning-Ward TF; Fidock DA; Thathy V; Menard R; van Spaendonk RM; Waters AP; Janse CJ
Mol Biochem Parasitol; 2000 Mar; 106(2):199-212. PubMed ID: 10699250
[TBL] [Abstract][Full Text] [Related]
5. Quantitative isolation and in vivo imaging of malaria parasite liver stages.
Tarun AS; Baer K; Dumpit RF; Gray S; Lejarcegui N; Frevert U; Kappe SH
Int J Parasitol; 2006 Oct; 36(12):1283-93. PubMed ID: 16890231
[TBL] [Abstract][Full Text] [Related]
6. Identifying antimalarial compounds targeting dihydrofolate reductase-thymidylate synthase (DHFR-TS) by chemogenomic profiling.
Aroonsri A; Akinola O; Posayapisit N; Songsungthong W; Uthaipibull C; Kamchonwongpaisan S; Gbotosho GO; Yuthavong Y; Shaw PJ
Int J Parasitol; 2016 Jul; 46(8):527-35. PubMed ID: 27150044
[TBL] [Abstract][Full Text] [Related]
7. Stable transfection of malaria parasite blood stages.
van Dijk MR; Waters AP; Janse CJ
Science; 1995 Jun; 268(5215):1358-62. PubMed ID: 7761856
[TBL] [Abstract][Full Text] [Related]
8. Transfection of malaria parasites.
Waters AP; Thomas AW; van Dijk MR; Janse CJ
Methods; 1997 Oct; 13(2):134-47. PubMed ID: 9405197
[TBL] [Abstract][Full Text] [Related]
9. A novel Plasmodium falciparum expression system for assessing antifolate resistance caused by mutant P. vivax dihydrofolate reductase-thymidylate synthase.
O'Neil MT; Korsinczky ML; Gresty KJ; Auliff A; Cheng Q
J Infect Dis; 2007 Aug; 196(3):467-74. PubMed ID: 17597462
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium yoelii yoelii 17XNL constitutively expressing GFP throughout the life cycle.
Ono T; Tadakuma T; Rodriguez A
Exp Parasitol; 2007 Mar; 115(3):310-3. PubMed ID: 17049517
[TBL] [Abstract][Full Text] [Related]
11. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
[TBL] [Abstract][Full Text] [Related]
12. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
Ishih A; Miyase T; Ohori K; Terada M
Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
[TBL] [Abstract][Full Text] [Related]
13. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
[TBL] [Abstract][Full Text] [Related]
14. Rhop-3 protein conservation among Plasmodium species and induced protection against lethal P. yoelii and P. berghei challenge.
Wang T; Fujioka H; Drazba JA; Sam-Yellowe TY
Parasitol Res; 2006 Aug; 99(3):238-52. PubMed ID: 16541261
[TBL] [Abstract][Full Text] [Related]
15. Tagging genes and trapping promoters in Toxoplasma gondii by insertional mutagenesis.
Roos DS; Sullivan WJ; Striepen B; Bohne W; Donald RG
Methods; 1997 Oct; 13(2):112-22. PubMed ID: 9405195
[TBL] [Abstract][Full Text] [Related]
16. Expansion of experimental genetics approaches for Plasmodium berghei with versatile transfection vectors.
Kooij TW; Rauch MM; Matuschewski K
Mol Biochem Parasitol; 2012 Sep; 185(1):19-26. PubMed ID: 22705315
[TBL] [Abstract][Full Text] [Related]
17. Expression of a Plasmodium gene introduced into subtelomeric regions of Plasmodium berghei chromosomes.
van Dijk MR; Janse CJ; Waters AP
Science; 1996 Feb; 271(5249):662-5. PubMed ID: 8571132
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
[TBL] [Abstract][Full Text] [Related]
19. Induction of hepatic inflammatory response by Plasmodium berghei sporozoites protects BALB/c mice against challenge with Plasmodium yoelii sporozoites.
Vanderberg JP; Khan ZM; Stewart MJ
J Parasitol; 1993 Oct; 79(5):763-7. PubMed ID: 8410550
[TBL] [Abstract][Full Text] [Related]
20. Pyrimethamine induces oxidative stress in Plasmodium yoelii 17XL-infected mice: a novel immunomodulatory mechanism of action for an old antimalarial drug?
Legorreta-Herrera M; Retana-Ugalde R; Ventura-Gallegos JL; Narváez V
Exp Parasitol; 2010 Nov; 126(3):381-8. PubMed ID: 20193682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
